Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism Mat2A inhibitors(S-adenosylmethionine synthase isoform type-2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Central Nervous System Diseases | Preclinical | US | 16 Mar 2022 |